SUBSCRIBE
SUBSCRIBE
News   Business

Signature Genomic Laboratories, LLC and SciGene Corporation Develop High-Throughput Microarray Diagnostics Platform

April 18, 2007 | 
1 min read
April 18, 2007, Sunnyvale, CA — Signature Genomic Laboratories, LLC (Spokane, WA) and SciGene (Sunnyvale, CA) announced the successful development of a method for processing SignatureChip® technology using SciGene’s microarray automation and ozone control systems.
Alliances
MORE ON THIS TOPIC
Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
February 6, 2026
 · 
2 min read
 · 
Annalee Armstrong
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
February 6, 2026
 · 
5 min read
 · 
Tristan Manalac
FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
 · 
1 min read
 · 
Tristan Manalac
Illustration of woman in black holding a surreal mirror among clouds, surreal abstract concept
Editorial
Novo Will Never Beat Lilly. Why Does It Have To?
February 5, 2026
 · 
3 min read
 · 
Annalee Armstrong